However, owing to the specific cellular and structural microenvironment in the brain and the relationship between PD-L1 and T cell infiltration in glioma, the therapeutic effects of anti-PD-1/PD-L1 antibodies remain unclear (Huang et al., 2017). Here, CD274 is linked to central nervous system cancer.